Skip to main content
padlock icon - secure page this page is secure

Aripiprazole-Induced Pathological Gambling: A Report of 3 Cases

Buy Article:

$63.00 + tax (Refund Policy)

We report three cases of pathological gambling induced by Aripiprazole, in patients with schizophrenia or schizoaffective disorder. All three patients had no history of pathological gambling, and they started gambling after initiation of treatment with Aripiprazole. The fact that pathological behavior disappeared quickly as medication ends suggests that an elaborate behavioral manifestation could be related to dopaminergic tone in patients with schizophrenia. We recommend consideration with increased attention for the appearance of pathological gambling symptoms among patients on Aripiprazole.





No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Age; Amilsupride; Aripiprazole; DSM -IV; Gender (M/F); Haldol; Hypersexuality; ICD; MCL; MINI; PG; Pathological Gambling; Pathological gambling; Risperidone; SOGS; behavioral addiction; bipolar disorder; compulsive eating; dopamine D3 receptor; dopamine agonist; dopaminergic; hypersexuality; schizoaffective disorder; schizophrenia; stimulation

Document Type: Research Article

Publication date: February 1, 2011

More about this publication?
  • Current Drug Safety publishes frontier reviews on all the latest advances on drug safety. The journal's aim is to publish the highest quality review articles in the field. Topics covered include: adverse effects of individual drugs and drug classes, management of adverse effects, pharmacovigilance and pharmacoepidemiology of new and existing drugs, post-marketing surveillance. The journal is essential reading for all researchers and clinicians involved in drug safety.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more